62 results on '"van de Warrenburg, Bart P"'
Search Results
2. An MRI evaluation of white matter involvement in paradigmatic forms of spastic ataxia: results from the multi-center PROSPAX study
3. Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration
4. Using Smartphone Sensors for Ataxia Trials: Consensus Guidance by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers
5. Cognitive Complaints and Their Impact on Daily Life in Patients with Degenerative Cerebellar Disorders
6. Preferences for genetic interventions for SCA and Huntington’s disease: results of a discrete choice experiment among patients
7. The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy
8. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND)
9. Perceptual and Acoustic Analysis of Speech in Spinocerebellar ataxia Type 1
10. Correction: Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration
11. The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study
12. Correction to: The frequency of non‑motor symptoms in SCA3 and their association with disease severity and lifestyle factors
13. The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors
14. Prevalence of intronic repeat expansions in RFC1 in Dutch patients with CANVAS and adult-onset ataxia
15. Increased trunk movements in people with hereditary spastic paraplegia: do these involve balance correcting strategies?
16. Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia Type 3: a Randomized, Double-Blind, Sham-Controlled Trial
17. The complexities of CACNA1A in clinical neurogenetics
18. Pharmacological and non-pharmacological management of spinocerebellar ataxia: A systematic review
19. Neurocognitive Changes in Spinocerebellar Ataxia Type 3: A Systematic Review with a Narrative Design
20. Correction to: The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study
21. Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias
22. Discordance Between Patient-Reported Outcomes and Physician-Rated Motor Symptom Severity in Early-to-Middle-Stage Spinocerebellar Ataxia Type 3
23. The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients
24. Systematic analysis of short tandem repeats in 38,095 exomes provides an additional diagnostic yield
25. A word of hope for ataxia trials in COVID-19 time and beyond
26. Correction to: Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3 (SCA3-tDCS): rationale and protocol of a randomized, double-blind, sham-controlled study
27. Improving gait adaptability in patients with hereditary spastic paraplegia (Move-HSP): study protocol for a randomized controlled trial
28. Healthcare needs, expectations, utilization, and experienced treatment effects in patients with hereditary spastic paraplegia: a web-based survey in the Netherlands
29. De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability
30. Classic ataxia-telangiectasia: the phenotype of long-term survivors
31. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia
32. COVID-19 reveals influence of physical activity on symptom severity in hereditary spastic paraplegia
33. Cerebellaire ataxie
34. Abnormal eyeblink conditioning is an early marker of cerebellar dysfunction in preclinical SCA3 mutation carriers
35. Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
36. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
37. Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands
38. Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3 (SCA3-tDCS): rationale and protocol of a randomized, double-blind, sham-controlled study
39. StartReact during gait initiation reveals differential control of muscle activation and inhibition in patients with corticospinal degeneration
40. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias
41. The clinical heterogeneity of drug-induced myoclonus: an illustrated review
42. No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs
43. Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia
44. Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6
45. Altered striatal and pallidal connectivity in cervical dystonia
46. Normal eyeblink classical conditioning in patients with fixed dystonia
47. The effectiveness of allied health care in patients with ataxia: a systematic review
48. Physiotherapy in Degenerative Cerebellar Ataxias: Utilisation, Patient Satisfaction, and Professional Expertise
49. Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series
50. Mechanisms of postural instability in hereditary spastic paraplegia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.